Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, and National Center of Excellence for Computational Drug Abuse Research, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.
Department of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng, Jiangsu 224005, China.
ACS Chem Neurosci. 2021 May 5;12(9):1606-1620. doi: 10.1021/acschemneuro.1c00082. Epub 2021 Apr 15.
Characterizing the structural basis of ligand recognition of adenosine A receptor (AAR) will facilitate its rational design and development of small molecules with high affinity and selectivity, as well as optimal therapeutic effects for pain, cancers, drug abuse disorders, etc. In the present work, we applied our reported algorithm, molecular complex characterizing system (MCCS), to characterize the binding features of AAR based on its reported 3D structures of protein-ligand complexes. First, we compared the binding score to the reported experimental binding affinities of each compound. Then, we calculated an output example of residue energy contribution using MCCS and compared the results with data obtained from MM/GBSA. The consistency in results indicated that MCCS is a powerful, fast, and accurate method. Sequentially, using a receptor-ligand data set of 57 crystallized structures of AARs, we characterized the binding features of the binding pockets in AAR, summarized the key residues that distinguish antagonist from agonist, produced heatmaps of residue energy contribution for clustering various statuses of AARs, explored the selectivity between AAR and AAR, etc. All the information provided new insights into the protein features of AAR and will facilitate its rational drug design.
阐明腺苷 A 受体(AAR)配体识别的结构基础,将有助于其合理设计和开发具有高亲和力和选择性的小分子,以及用于治疗疼痛、癌症、药物滥用障碍等的最佳治疗效果。在本工作中,我们应用了我们报道的算法,分子复合物特征化系统(MCCS),基于 AAR 已报道的蛋白-配体复合物的三维结构,来描绘 AAR 的结合特征。首先,我们比较了结合评分与每个化合物报道的实验结合亲和力。然后,我们使用 MCCS 计算了残基能量贡献的输出示例,并将结果与 MM/GBSA 获得的数据进行了比较。结果的一致性表明 MCCS 是一种强大、快速和准确的方法。随后,我们使用 AAR 的 57 个结晶结构的受体-配体数据集,描绘了 AAR 结合口袋的结合特征,总结了区分拮抗剂和激动剂的关键残基,为聚类各种 AAR 状态生成了残基能量贡献的热图,探索了 AAR 和 AAR 之间的选择性等。所有这些信息为 AAR 的蛋白特征提供了新的见解,并将有助于其合理的药物设计。